Associations between trajectories of obesity prevalence in English primary school children and the UK soft drink industry levy: an interrupted time series analysis of surveillance data - Rogers, Nina T.; Cummins, Steven; Forde, Hannah; Jones, Catrin P.; Mytton, Oliver; Rutter, Harry; Sharp, Stephen J.; Theis, Dolly; White, Martin; Adams, Jean (medRxiv, 2022)
Background Sugar sweetened beverages (SSBs) are the primary source of dietary added sugars in children, with high consumption commonly observed in more deprived areas where obesity prevalence is also highest. Associations between SSB consumption and obesity in children have been widely reported. In March 2016, a two-tier soft drinks industry levy (SDIL) on drinks manufacturers to encourage reformulation of SSBs in the UK was announced, and then implemented in April 2018. We examined trajectories in the prevalence of obesity at ages 4-5 years and 10-11 years, 19 months after the implementation of SDIL, overall and by sex and deprivation.Methods and Findings Data were from the National Child Measurement Programme and included annual repeat cross-sectional measurement of over one million children aged 4-5 and 10-11 years in state-maintained primary schools. Interrupted time series analysis of monthly obesity prevalence data from September 2013 to November 2019 was used to estimate absolute and relative changes in obesity prevalence compared to a counterfactual (adjusted for temporal variations in obesity prevalence) estimated from the trend prior to SDIL announcement. Differences between observed and counterfactual estimates were examined in November 2019 by age (4-5 or 10-11 years) and additionally by sex and deprivation quintile. In 10-11 year old children there was an overall absolute reduction in obesity prevalence (defined as >95th centile on the UK90 growth charts) of 0.8% (95%CI: 0.3, 1.3). In 10-11 year old girls the reduction was 1.6% (95%CI: 1.1, 2.1), with greatest reductions in the two most deprived quintiles (e.g. there was an absolute reduction of 2.4% (95%CI: 1.6, 3.2) in prevalence of obesity in the most deprived quintile). In 10-11 year old boys, there was no change in obesity prevalence, except in the least deprived quintile where there was a 1.6% (95%CI: 0.7,2.5) absolute increase. In 4-5 year old children, relative to the counterfactual, there were overall increases in obesity prevalence in both genders (combined) and all deprivation quintiles except the most deprived where there was no change.Conclusions Our results suggest the SDIL was associated with decreased prevalence of obesity in 10-11 year old girls, with the greatest effects in those living in the most deprived areas. Additional strategies beyond SSB taxation will be needed to reduce obesity prevalence overall, and particularly in older boys and younger children.Trial registration ISRCTN18042742Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding: NR, OM, MW, and JA were supported by the Medical Research Council (grant Nos MC_UU_00006/7). This project was funded by the NIHR Public Health Research programme (grant Nos 16/49/01 and 16/130/01). The views expressed are those of the authors and not necessarily those of the National Health Service, the NIHR, or the Department of Health and Social Care, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval: Not required for secondary data analysis of anonymised data.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors